Advisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
28/09/2026 13:19
ADVISORY-Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn An alert on LIB Therapeutics announcing a licensing agreement with Sun Pharma SUN.NS was inadvertently tagged to Sun Pharma Advanced Research SPRC.NS, an unrelated company, and has been withdrawn.
For the correctly coded alerts on Sun Pharma, click here.
STORY_NUMBER: nFWN45K0BP
STORY_DATE: 28/09/2026
STORY_TIME: 12:00 PM GMT
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees